세계의 동물용 항감염제 시장 보고서(2025년)
Veterinary Anti-infectives Global Market Report 2025
상품코드 : 1793359
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,498,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,393,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,288,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

동물용 항감염제 시장 규모는 앞으로 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 9.6%를 나타내 86억 9,000만 달러로 성장할 전망입니다. 예측기간의 성장은 반려동물 수의 지속적인 증가, 신흥인 짐승 공통 감염, 반려동물 거래의 세계화, 수의학 건강 관리 지출 증가에 기인합니다. 예측기간의 주요 동향으로는 기술의 진보, 생물학적 제제의 채용 증가, 동물의료서비스에서의 텔레헬스의 통합, 천연소재와 허브의 대체품에 대한 주목, 동물용의약품에 있어서의 전자상거래의 확대, 제휴 및 파트너십 등이 있습니다.

향후 5년간의 성장률 9.6%라고 하는 예측은 전회의 예측으로부터 0.1%의 미감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 멸균 입력과 발효 기반 활성제에 대한 관세는 생산 능력을 낮추고 새로운 항 감염 제제의 상시를 지연시킬 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

반려동물 사육 증가는 향후 동물용 항감염제 시장 성장을 이끌 것으로 예측됩니다. 반려동물 사육이란 가정에서 개나 고양이 등의 가축을 키우는 것을 말합니다. 반려동물을 가족의 일원으로 생각해, 키우는 젊은이가 늘어나고 있고, 많은 주인은 반려동물의 교우 관계, 충성심, 외로움을 완화시키는 능력에 동기 부여되고 있습니다. 예를 들어, 2022년 호주에 본부를 두고 있는 비정부 조직 Animal Medicines Australia의 데이터에 따르면 반려동물 소유자 수는 28,730.8명에 이르며 2021년 39%에서 크게 증가했습니다. 이는 반려동물 사육과 반려동물 케어에 대한 투자의 강한 증가 추세를 반영하여 24% 증가를 보여줍니다. 반려동물 사육 수 증가는 호주 가정에서 반려동물의 매력 증가를 돋보이게 합니다. 따라서 반려동물 사육 증가는 동물용 항감염제 시장 수요를 촉진하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

The term veterinary anti-infective encompasses a wide range of methods aimed at preventing and treating illnesses in animals. These products are utilized in veterinary medicine to promote the health and well-being of both livestock and pets, as well as to control disease outbreaks within animal populations.

The main types of drug classes in veterinary anti-infectives include antimicrobial agents, antiviral agents, antifungal agents, and others. Antimicrobial agents are substances, either natural or synthetic, that function by killing or inhibiting the growth of microorganisms such as bacteria, fungi, and algae. Various species, including livestock animals and companion animals, are involved in the administration of these drugs through oral, parenteral, and topical modes. Distribution channels for veterinary anti-infectives include veterinary hospitals, veterinary clinics, pharmacies, and other relevant outlets.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The veterinary anti-infectives market research report is one of a series of new reports from The Business Research Company that provides veterinary anti-infectives market statistics, including veterinary anti-infectives industry global market size, regional shares, competitors with veterinary anti-infectives market share, detailed veterinary anti-infectives market segments, market trends, and opportunities, and any further data you may need to thrive in the veterinary anti-infectives industry. This veterinary anti-infectives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The veterinary anti-infectives market size has grown strongly in recent years. It will grow from $5.54 billion in 2024 to $6.02 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing pet ownership, prevalence of infectious diseases, advancements in veterinary medicine, rising awareness, government initiatives.

The veterinary anti-infectives market size is expected to see strong growth in the next few years. It will grow to $8.69 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to continued pet population growth, emerging zoonotic diseases, globalization of pet trade, increasing veterinary healthcare expenditure. Major trends in the forecast period include technological advancements, increasing adoption of biologicals, integration of telehealth in veterinary services, focus on natural and herbal alternatives, expansion of e-commerce in veterinary pharmaceuticals, collaborations and partnerships.

The forecast of 9.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariffs on sterilization inputs and fermentation-based actives could reduce production capacity and delay the launch of new anti-infective formulations. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

An increase in pet ownership is anticipated to drive the growth of the veterinary anti-infectives market in the future. Pet ownership refers to having dogs, cats, or other domestic animals at home. More young individuals are adopting pets, viewing them as family members, and many owners are motivated by the pets' companionship, loyalty, and ability to alleviate loneliness. For instance, in 2022, data from Animal Medicines Australia, a non-governmental organization based in Australia, indicated a significant rise in pet ownership, with the number of pet owners reaching 28,730.8, compared to 39% in 2021. This marks a 24% increase, reflecting a strong upward trend in pet adoption and investment in pet care. The rise in pet ownership highlights the growing appeal of pets within Australian households. Thus, the increase in pet ownership is fueling demand for the veterinary anti-infectives market.

The veterinary anti-infectives market is expected to witness growth due to the increasing trend of rising livestock production. Livestock, including cattle, sheep, pigs, chickens, and goats, are raised for various purposes, such as food production, labor, and companionship. Veterinary anti-infectives play a crucial role in treating infections in animals, ensuring their health and well-being, and preventing and controlling diseases. According to the National Agricultural Statistics Service, in the US, there were approximately 28. 9 million beef cows, 9. 4 million dairy cows, and an estimated 11. 1 million cattle on feed in 2022. The expanding livestock production contributes to the growth of the veterinary anti-infectives market.

Major players in the veterinary anti-infectives market are forming strategic partnerships to address the threat of antimicrobial resistance (AMR). Strategic partnerships involve companies utilizing each other's strengths and resources to achieve mutual benefits and success. For example, in November 2022, the Food and Agriculture Organization of the United Nations (FAO), the UN Environment Programme (UNEP), the World Health Organization (WHO), and the World Organization for Animal Health (WOAH), collectively known as the Quadripartite, launched the Antimicrobial Resistance Multi-Stakeholder Partnership Platform. This initiative aims to highlight the risks that AMR poses to humans, animals, plants, ecosystems, and livelihoods, as well as to ensure that the increasing challenges and consequences of antimicrobial resistance are addressed on a global scale.

Strategic partnerships are another significant approach adopted by major players in the veterinary anti-infectives market to address the threat of antimicrobial resistance. In November 2022, The Food and Agriculture Organization of the United Nations (FAO), the UN Environment Programme (UNEP), the World Health Organization (WHO), and the World Organization for Animal Health (WOAH) jointly launched The Antimicrobial Resistance Multi-Stakeholder Partnership Platform. This initiative aims to highlight the global threat posed by antimicrobial resistance and ensure a coordinated international effort to address its challenges and consequences.

In June 2022, Ceva Sante Animale, a multinational animal health company based in France, acquired Artemis Technologies, Inc., a Canada-based oral rabies vaccine manufacturer, for an undisclosed amount. This strategic acquisition enhances Ceva's rabies portfolio and expands its market footprint in North America.

Major companies operating in the veterinary anti-infectives market include Bayer AG, C. H. Boehringer Sohn AG & Co. KG, Ceva Sante Animale, Elanco Animal Health Incorporated, Zoetis Inc., Vetoquinol S. A., Merck & Co., Phibro Animal Health, Aspen Veterinary Resources Ltd., Bimeda Animal Health Limited, Dechra Pharmaceuticals Plc, Intervet International B. V., Oceanic Pharmachem Pvt. Ltd., Virbac Ltd., Indian Immunologicals Ltd. (IIL), Norbrook Laboratories Ltd., Ashish Life Science Pvt. Ltd., Kyoritsu Seiyaku Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., HIPRA, Zydus Animal Health and Investments Limited, China Animal Husbandry Group, ZOOVETVARU Ltd., Magnum Veterinaaria Ltd., Inovet (V. M. D. nv/sa), Chanelle Pharmaceuticals Manufacturing Ltd., Huvepharma Inc., Veyx Pharma GmbH, Biovet Pvt. Ltd., Laboratorios Ovejero SA, Laboratorios Syva S. A.

North America was the largest region in the veterinary anti-infectives market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the veterinary anti-infectives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The veterinary anti-infectives market consists of revenues earned by entities by providing antibacterial that are used to prevent and treat animal diseases such as infections. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Anti-infectives Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary anti-infectives market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for veterinary anti-infectives ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary anti-infectives market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Veterinary Anti-infectives Market Characteristics

3. Veterinary Anti-infectives Market Trends And Strategies

4. Veterinary Anti-infectives Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Veterinary Anti-infectives Growth Analysis And Strategic Analysis Framework

6. Veterinary Anti-infectives Market Segmentation

7. Veterinary Anti-infectives Market Regional And Country Analysis

8. Asia-Pacific Veterinary Anti-infectives Market

9. China Veterinary Anti-infectives Market

10. India Veterinary Anti-infectives Market

11. Japan Veterinary Anti-infectives Market

12. Australia Veterinary Anti-infectives Market

13. Indonesia Veterinary Anti-infectives Market

14. South Korea Veterinary Anti-infectives Market

15. Western Europe Veterinary Anti-infectives Market

16. UK Veterinary Anti-infectives Market

17. Germany Veterinary Anti-infectives Market

18. France Veterinary Anti-infectives Market

19. Italy Veterinary Anti-infectives Market

20. Spain Veterinary Anti-infectives Market

21. Eastern Europe Veterinary Anti-infectives Market

22. Russia Veterinary Anti-infectives Market

23. North America Veterinary Anti-infectives Market

24. USA Veterinary Anti-infectives Market

25. Canada Veterinary Anti-infectives Market

26. South America Veterinary Anti-infectives Market

27. Brazil Veterinary Anti-infectives Market

28. Middle East Veterinary Anti-infectives Market

29. Africa Veterinary Anti-infectives Market

30. Veterinary Anti-infectives Market Competitive Landscape And Company Profiles

31. Veterinary Anti-infectives Market Other Major And Innovative Companies

32. Global Veterinary Anti-infectives Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Anti-infectives Market

34. Recent Developments In The Veterinary Anti-infectives Market

35. Veterinary Anti-infectives Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기